scorecardresearch
Follow Us:
Sunday, March 07, 2021

Brazil health regulator approves additional AstraZeneca vaccine imports

Brazil is in the midst of the world’s second deadliest outbreak of COVID-19 after the United States.

By: Reuters | Brasilia |
February 13, 2021 1:28:21 pm
Serum Institute of India, Covid vaccine, Tie up with SII, Astrazeneca, Novavax, Indian expressThe cost of the doses and the dose agreements will provide no profits for AstraZeneca. (Bloomberg Photo: Anthony Devlin/File)

Brazil’s health regulator Anvisa on Friday approved a request by biomedical institute Fiocruz to import more doses of the vaccine developed by AstraZeneca and the University of Oxford from the Serum Institute of India, without specifying how many.

Also on Friday, Fiocruz said in a statement, without referencing Anvisa’s approval, that it was negotiating imports of 2 million more doses from the Serum Institute, in addition to 2 million already agreed.

Brazil, which is in the midst of the world’s second deadliest outbreak of COVID-19 after the United States, has thus far only authorized AstraZeneca vaccine and another developed by China’s SinoVac for emergency use.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest World News, download Indian Express App.

0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement